PGIMER develops imaging modality to determine tumour

Today News Online Service

Chandigarh, March 16

Endocrinology and nuclear medicine department of the PGI here has developed an imaging modality to identify and delineate tumours found in the pituitary gland.

Dr Rama Walia shared: “This modality is known as Ga 68 CRH PET-CT. This imaging could localise the tumour in all patients studied by a team. This technique has been developed for the first time in the world and we have applied for a patent for this. This could delineate tumour in all 24 cases studied by the team.”

Prof Sanjay Kumar Bhadada said: “This innovative modality will enable us to detect the Cushing’s disease at an earlier level..”

It took five years for the team to prepare this imaging modality. Cushing’s syndrome is a hormonal disorder associated with excess production of cortisol. Cortisol is a hormone produced by the body to fight stress.

Institute to carry out study on diabetics

The PGI is planning to bring diabetes to remission using intensive medical therapy in a three-month study. The criteria for enrolment in the study are age less than 65 years, diabetes of less than 2 years duration, HbA1c

Be the first to comment on "PGIMER develops imaging modality to determine tumour"

Leave a comment

Your email address will not be published.


%d bloggers like this: